ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 248 filers reported holding ALKERMES PLC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,113 | +44.5% | 170,649 | +67.9% | 0.03% | +3.7% |
| Q3 2023 | $2,847 | +146.1% | 101,647 | +175.1% | 0.03% | +200.0% |
| Q2 2023 | $1,157 | -74.3% | 36,954 | -76.8% | 0.01% | -75.7% |
| Q1 2023 | $4,495 | +29.5% | 159,456 | +20.1% | 0.04% | -26.0% |
| Q4 2022 | $3,470 | -99.9% | 132,804 | +27.0% | 0.05% | +61.3% |
| Q3 2022 | $2,334,000 | +476.3% | 104,530 | +668.2% | 0.03% | +520.0% |
| Q2 2022 | $405,000 | -33.6% | 13,608 | -41.3% | 0.01% | -37.5% |
| Q1 2022 | $610,000 | -18.7% | 23,194 | -42.2% | 0.01% | -27.3% |
| Q1 2021 | $750,000 | -18.1% | 40,136 | -12.6% | 0.01% | +22.2% |
| Q4 2020 | $916,000 | -38.6% | 45,920 | -49.0% | 0.01% | -70.0% |
| Q3 2020 | $1,492,000 | +594.0% | 90,018 | +754.4% | 0.03% | +650.0% |
| Q4 2019 | $215,000 | -14.7% | 10,536 | -18.3% | 0.00% | -55.6% |
| Q3 2019 | $252,000 | – | 12,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,030,639 | $51,872,000 | 38.88% |
| Tamarack Capital Management, LLC | 525,000 | $25,573,000 | 5.22% |
| Gerry Farber, LLC | 83,000 | $4,177,000 | 4.33% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 140,375 | $7,065,000 | 2.71% |
| Rhenman & Partners Asset Management AB | 168,000 | $8,455,000 | 2.51% |
| First Light Asset Management, LLC | 63,684 | $3,205,000 | 2.16% |
| Iguana Healthcare Management, LLC | 85,000 | $4,278,000 | 2.00% |
| Granahan Investment Management | 1,057,300 | $53,214,000 | 1.55% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,602,431 | $181,310,000 | 1.33% |
| Cormorant Asset Management, LP | 100,000 | $5,033,000 | 1.33% |